Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.147 HKD | +13.08% | +13.08% | +8.89% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,490 | 251.6 | 224.5 | 1,509 | 801.1 | 178.8 |
Enterprise Value (EV) 1 | 1,271 | 26.17 | 77.25 | 1,477 | 801.5 | 130.5 |
P/E ratio | 68.8 x | -0.11 x | -0.27 x | -131 x | 518 x | -198 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.45 x | 1.4 x | 1.55 x | 19 x | 9.78 x | 1.78 x |
EV / Revenue | 4.65 x | 0.15 x | 0.53 x | 18.6 x | 9.79 x | 1.3 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - |
Price to Book | 0.36 x | 0.16 x | 0.24 x | 3.52 x | 1.81 x | 0.45 x |
Nbr of stocks (in thousands) | 387,010 | 387,010 | 387,010 | 387,010 | 387,010 | 425,711 |
Reference price 2 | 3.850 | 0.6500 | 0.5800 | 3.900 | 2.070 | 0.4200 |
Announcement Date | 18-04-26 | 19-04-26 | 20-05-14 | 21-04-29 | 22-06-28 | 23-04-28 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 273.3 | 180 | 145.3 | 79.6 | 81.89 | 100.3 |
EBITDA | - | - | - | - | - | - |
EBIT | - | - | - | - | - | - |
Operating Margin | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | 128.7 | -2,179 | -812.4 | -9.172 | 6.96 | 9.323 |
Net income 1 | 82.27 | -2,199 | -825.7 | -11.49 | 6.055 | -0.904 |
Net margin | 30.1% | -1,221.39% | -568.39% | -14.43% | 7.39% | -0.9% |
EPS 2 | 0.0560 | -5.682 | -2.133 | -0.0297 | 0.004000 | -0.002123 |
Free Cash Flow | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 18-04-26 | 19-04-26 | 20-05-14 | 21-04-29 | 22-06-28 | 23-04-28 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 0.42 | - |
Net Cash position 1 | 219 | 225 | 147 | 32.1 | - | 48.3 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | 2.12% | -76.4% | -65.2% | -1.5% | 1.34% | 0.16% |
ROA (Net income/ Total Assets) | 2.07% | -73.1% | -56.3% | -1.25% | 1.25% | 0.14% |
Assets 1 | 3,974 | 3,010 | 1,468 | 916.5 | 486.2 | -646.6 |
Book Value Per Share 2 | 10.70 | 3.980 | 2.440 | 1.110 | 1.150 | 0.9300 |
Cash Flow per Share 2 | 0.5700 | 0.4600 | 0.4000 | 0.1100 | 0.0500 | 0.1400 |
Capex 1 | 0.29 | 29.4 | - | 1.35 | 0.89 | 1.03 |
Capex / Sales | 0.11% | 16.34% | - | 1.7% | 1.09% | 1.03% |
Announcement Date | 18-04-26 | 19-04-26 | 20-05-14 | 21-04-29 | 22-06-28 | 23-04-28 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+8.89% | 7.58M | |
-6.39% | 51.37B | |
-4.42% | 31.37B | |
+58.94% | 28.64B | |
+20.90% | 24.24B | |
+21.48% | 18.31B | |
+5.19% | 13.19B | |
+24.06% | 11.67B | |
+13.42% | 8.19B | |
-28.07% | 7.35B |
- Stock Market
- Equities
- 767 Stock
- Financials Zhong Ji Longevity Science Group Limited